Search results
At OncoStem, we develop innovative prognostic tests that assess aggressiveness of tumours based on in-depth knowledge of tumour biology, to identify the unique characteristics of cancer recurrence risk.
Founded in 2011, OncoStem aims to develop innovative tests to personalize treatment for cancer patients. Understanding of tumor biology aids physicians in optimizing therapy for cancer...
Keen on signing up nationwide diagnostic chains to achieve a longer reach of its services from Kashmir to Kanyakumari, OncoStem hopes to touch the lives of every needy patient across India via these chains and direct tie-ups.
This led to the creation of Oncostem Diagnostics by Dr. Bakre. The startup's solution CanAssist Breast is a game-changer in machine-learning based cancer detection. Read all about Dr. Bakre's journey as a healthtech entrepreneur. Published By : Sindhuja Balaji.
Founded in 2011, OncoStem develops highly innovative multi-marker prognostic test for breast cancer that identify patterns of recurrence amongst patients. Our expertise in tumor biology assists physicians in developing optimal therapeutic plans for patients.
By interviewing Oncostem Diagnostics, we aim to understand and review the role of AI as a decisive technology to analyze, prepare us for prevention, and fight with COVID-19 (Coronavirus) and other such pandemics.
OncoStem Diagnostics Pvt. Ltd. #4, Raja Ram Mohan Roy Road, Aanand Tower, 2nd Floor, Bengaluru - 560027. +91 96866 96505 / +91 80222 40034.
